Iran’s annual gas production reaches 275 bcm: Oil ministerIowa's O hopes to stay hot vs. defense-minded Northwestern

A judge has once again rejected Musk’s multi-billion-dollar Tesla pay package. Now what?The world’s 10 richest people: The wealthiest have $100 billion or more

Roy Keane clashes with Ian Wright during Man United's defeat by Arsenal - as former Red Devils hardman slams 'f***ing rubbish' display from Ruben Amorim's sideTHOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE AmgenSnack maker Hearthside files for bankruptcy after child labor probe

By TOM KRISHER, Associated Press DETROIT (AP) — For a second time, a Delaware judge has nullified a pay package that Tesla had awarded its CEO, Elon Musk, that once was valued at $56 billion. On Monday, Chancellor Kathaleen St. Jude McCormick turned aside a request from Musk’s lawyers to reverse a ruling she announced in January that had thrown out the compensation plan. The judge ruled then that Musk effectively controlled Tesla’s board and had engineered the outsize pay package during sham negotiations . Lawyers for a Tesla shareholder who sued to block the pay package contended that shareholders who had voted for the 10-year plan in 2018 had been given misleading and incomplete information. In their defense, Tesla’s board members asserted that the shareholders who ratified the pay plan a second time in June had done so after receiving full disclosures, thereby curing all the problems the judge had cited in her January ruling. As a result, they argued, Musk deserved the pay package for having raised Tesla’s market value by billions of dollars. McCormick rejected that argument. In her 103-page opinion, she ruled that under Delaware law, Tesla’s lawyers had no grounds to reverse her January ruling “based on evidence they created after trial.” On Monday night, Tesla posted on X, the social media platform owned by Musk, that the company will appeal. The appeal would be filed with the Delaware Supreme Court, the only state appellate court Tesla can pursue. Experts say a ruling would likely come in less than a year. “The ruling, if not overturned, means that judges and plaintiffs’ lawyers run Delaware companies rather than their rightful owners — the shareholders,” Tesla argued. Later, on X, Musk unleashed a blistering attack on the judge, asserting that McCormick is “a radical far left activist cosplaying as a judge.” Legal authorities generally suggest that McCormick’s ruling was sound and followed the law. Charles Elson, founding director of the Weinberg Center for Corporate Governance at the University of Delaware, said that in his view, McCormick was right to rule that after Tesla lost its case in the original trial, it created improper new evidence by asking shareholders to ratify the pay package a second time. Had she allowed such a claim, he said, it would cause a major shift in Delaware’s laws against conflicts of interest given the unusually close relationship between Musk and Tesla’s board. “Delaware protects investors — that’s what she did,” said Elson, who has followed the court for more than three decades. “Just because you’re a ‘superstar CEO’ doesn’t put you in a separate category.” Elson said he thinks investors would be reluctant to put money into Delaware companies if there were exceptions to the law for “special people.” Elson said that in his opinion, the court is likely to uphold McCormick’s ruling. Experts say no. Rulings on state laws are normally left to state courts. Brian Dunn, program director for the Institute of Compensation Studies at Cornell University, said it’s been his experience that Tesla has no choice but to stay in the Delaware courts for this compensation package. The company could try to reconstitute the pay package and seek approval in Texas, where it may expect more friendlier judges. But Dunn, who has spent 40 years as an executive compensation consultant, said it’s likely that some other shareholder would challenge the award in Texas because it’s excessive compared with other CEOs’ pay plans. Related Articles “If they just want to turn around and deliver him $56 billion, I can’t believe somebody wouldn’t want to litigate it,” Dunn said. “It’s an unconscionable amount of money.” Almost certainly. Tesla stock is trading at 15 times the exercise price of stock options in the current package in Delaware, Morgan Stanley analyst Adam Jonas wrote in a note to investors. Tesla’s share price has doubled in the past six months, Jonas wrote. At Monday’s closing stock price, the Musk package is now worth $101.4 billion, according to Equilar, an executive data firm. And Musk has asked for a subsequent pay package that would give him 25% of Tesla’s voting shares. Musk has said he is uncomfortable moving further into artificial intelligence with the company if he doesn’t have 25% control. He currently holds about 13% of Tesla’s outstanding shares.

Standard Chartered Bank, India, launches “FEMA Centre of Excellence”

WASHINGTON — The Supreme Court seemed likely Wednesday to uphold Tennessee's ban on gender-affirming care for minors. The justices' decision, not expected for several months, could affect similar laws enacted by another 25 states and a range of other efforts to regulate the lives of transgender people, including which sports competitions they can join and which restrooms they can use. The case is being weighed by a conservative-dominated court after a presidential election in which Donald Trump and his allies promised to roll back protections for transgender people. The Biden administration's top Supreme Court lawyer warned a decision favorable to Tennessee also could be used to justify nationwide restrictions on transgender health care for minors. In arguments that lasted more than two hours, five of the six conservative justices voiced varying degrees of skepticism over arguments made by the administration and Chase Strangio, the ACLU lawyer for Tennessee families challenging the ban. Chief Justice John Roberts, who voted in the majority in a 2020 case in favor of transgender rights, questioned whether judges, rather than lawmakers, should weigh in on a question of regulating medical procedures, an area usually left to the states. "The Constitution leaves that question to the people's representatives, rather than to nine people, none of whom is a doctor," Roberts said in an exchange with Strangio. Justice Neil Gorsuch, who wrote the majority opinion in 2020, said nothing during the arguments. The court's three liberal justices seemed firmly on the side of the challengers, but it's not clear that any conservatives will go along. Justice Sonia Sotomayor pushed back against the assertion that the democratic process would be the best way to address objections to the law. She cited a history of laws discriminating against others, noting that transgender people make up less than 1% of the U.S. population, according to studies. There are an estimated 1.3 million adults and 300,000 adolescents ages 13 to 17 who identify as transgender, according the UCLA law school's Williams Institute. "Blacks were a much larger part of the population and it didn't protect them. It didn't protect women for whole centuries," Sotomayor said in an exchange with Tennessee Solicitor General Matt Rice. Justice Ketanji Brown Jackson said she saw some troubling parallels between arguments made by Tennessee and those advanced by Virginia and rejected by a unanimous court, in the 1967 Loving decision that legalized interracial marriage nationwide. Quoting from that decision, Jackson noted that Virginia argued then that "the scientific evidence is substantially in doubt and, consequently, the court should defer to the wisdom of the state legislature." Justice Samuel Alito repeatedly pressed Strangio, the first openly transgender lawyer to argue at the nation's highest court, about whether transgender people should be legally designated as a group that's susceptible to discrimination. Strangio answered that being transgender does fit that legal definition, though he acknowledged under Alito's questioning there are a small number of people who de-transition. "So it's not an immutable characteristic, is it?" Alito said. Strangio did not retreat from his view, though he said the court did not have to decide the issue to resolve the case in his clients' favor. There were dueling rallies outside the court in the hours before the arguments. Speeches and music filled the air on the sidewalk below the court's marble steps. Advocates of the ban bore signs like "Champion God's Design" and "Kids Health Matters," while the other side proclaimed "Fight like a Mother for Trans Rights" and "Freedom to be Ourselves." Four years ago, the court ruled in favor of Aimee Stephens, who was fired by a Michigan funeral home after she informed its owner she was a transgender woman. The court held that transgender people, as well as gay and lesbian people, are protected by a landmark federal civil rights law that prohibits sex discrimination in the workplace. The Biden administration and the families and health care providers who challenged the Tennessee law urged the justices to apply the same sort of analysis that the majority, made up of liberal and conservative justices, embraced in the case four years ago when it found that "sex plays an unmistakable role" in employers' decisions to punish transgender people for traits and behavior they otherwise tolerate. The issue in the Tennessee case is whether the law violates the equal protection clause of the 14th Amendment, which requires the government to treat similarly situated people the same. Tennessee's law bans puberty blockers and hormone treatments for transgender minors, but allows the same drugs to be used for other purposes. Solicitor General Elizabeth Prelogar, the administration's top Supreme Court lawyer, called the law sex-based line drawing to ban the use of drugs that have been safely prescribed for decades and said the state "decided to completely override the views of the patients, the parents, the doctors." She contrasted the Tennessee law with one enacted by West Virginia, which set conditions for the health care for transgender minors, but stopped short of an outright ban. Gender-affirming care for youth is supported by every major medical organization, including the American Medical Association, the American Academy of Pediatrics and the American Psychiatric Association.Intel CEO Pat Gelsinger announces his immediate retirement, marking the end of a challenging era for ... [+] the chipmaker. Intel’s announcement that CEO Pat Gelsinger has retired effective “immediately” marks a pivotal moment in the semiconductor giant’s history. The decision was surprising yet inevitable, signaling the end of an era that began with Gelsinger’s return to the company in 2021. As the company struggles with a challenging market and internal pressures, the question arises: Can Intel reclaim its edge in a fiercely competitive industry, or has it lost the "paranoia" that once made it an unstoppable force? Only the Paranoid Survive —But Has Intel Forgotten? Intel’s legendary former CEO, Andy Grove, famously declared, “Only the Paranoid Survive.” Under his leadership, this mantra became the company’s guiding principle. Grove’s paranoia wasn’t about fear; it was about constant vigilance and the relentless drive to innovate. This mindset propelled Intel from a struggling memory-chip maker to the leader in microprocessors, where it dominated the market for decades. When Pat Gelsinger returned as CEO in 2021, following his successful leadership roles at EMC and VMware , there was hope that he could restore Intel’s innovative edge and strategic clarity. A seasoned technologist with deep roots at Intel, Gelsinger took on the daunting task of rejuvenating the company’s fortunes. His bold IDM 2.0 strategy aimed to transform Intel into a manufacturing powerhouse and a leading foundry player. However, despite his clear vision and undeniable passion, the outcomes fell short of expectations. Intel’s stock has plummeted by over 50% this year, and the company suffered a record $17 billion loss last quarter, laying off over 15% of its workforce . Its manufacturing delays and missteps in AI left it far behind competitors like Nvidia, which has seized the leadership in AI chips, and TSMC, which has become the dominant force in chip manufacturing. To make matters worse, Intel was removed from the Dow Jones Industrial Average earlier this year—a symbolic blow to a company once at the pinnacle of tech innovation. While Gelsinger inherited significant challenges, his inability to execute at the pace required in today’s rapidly changing tech landscape led to his ousting. Intel, once the apex predator of the semiconductor world, is now scrambling to regain its footing. Save Up To 75% With The Best Black Friday Clothing Deals That Are Still Running 10 Unofficial Hoka Cyber Week Sales You Don’t Want To Miss The End of an Era—And The Start Of A Crossroads The abrupt departure of Gelsinger, following the board’s decision to replace him, marks the end of an era at Intel. While Gelsinger’s efforts to restore the company’s manufacturing capabilities and reestablish its competitive edge were admirable, they ultimately fell short in a market where innovation waits for no one. Intel’s board, frustrated with the pace of change, made the difficult decision to part ways with its CEO. With CFO David Zinsner and Client Computing Group GM Michelle Johnston Holthaus stepping in as interim co-CEOs, Intel is at a critical juncture. The next permanent CEO will face the monumental task of charting a new course for the company. Intel’s future depends on how well it adapts to new market realities and navigates the fierce competition in the semiconductor space. Three questions about Intel’s future have emerged: Rediscovering The Paranoid Spirit For Intel to succeed, it must rediscover the spirit of paranoia that served it so well in the past. Grove’s mantra wasn’t about fear—it was about staying ahead of the curve, anticipating disruption before it happened . In an industry where technological cycles are measured in months, not years, survival demands constant reinvention. Intel needs a leader who can reignite that hunger for innovation and disruption, one who can act with the same urgency that defined the company in its heyday. The next CEO must be someone who understands that, in today’s world, complacency is the greatest risk. There’s no time to dwell on past glory. What Lies Ahead Pat Gelsinger’s sudden departure is both a reflection of Intel’s struggles and a moment ripe for renewal. The company now faces a defining question: Will it reclaim the vigilance and boldness that once made it a powerhouse, or will it join the growing list of cautionary tales in the tech industry? As Andy Grove said, “Success breeds complacency. Complacency breeds failure. Only the paranoid survive.” Intel’s survival hinges on how deeply it can reconnect with that ethos—embracing a culture of relentless innovation and adaptability before external forces dictate its fate. The tech industry offers countless examples of once-dominant players that failed to pivot in the face of disruption . Intel’s challenges highlight a universal truth for leaders: nostalgia and legacy, while inspiring, are not strategies. Success demands not just vision, but flawless execution, especially in industries where the pace of innovation is unrelenting. For Gelsinger, this marks a bittersweet end to a remarkable career at the forefront of technological transformation. For Intel, it’s a stark reminder that even industry giants are not immune to irrelevance if they fail to adapt. As the world watches, Intel must answer the critical question Gelsinger himself posed at MIT just a year ago: “Will we manufacture the future?” The stakes couldn’t be higher. The tech industry—and its next chapter—depends on what happens next.* Key Square scored on Trump trade this year * Key Square's investment performance has been uneven since start * Hedge fund's assets are down nearly 90% since peak * Brevan Howard remains a client of Key Square By Lawrence Delevingne and Carolina Mandl BOSTON/NEW YORK, - As a money manager, Scott Bessent's years of inconsistent performance have contributed to a nearly 90% decline in his hedge fund's assets. Now, with some clients gone, he is scoring on perhaps his biggest bet yet: President-elect Donald Trump. Bessent spotted what he called an anomaly in the market: that political and market analysts were too negative on what a Trump victory would mean, according to a letter to clients in January seen by Reuters. His Key Square Capital Management put on bets that U.S. stocks and the dollar would gain, helping earn a double-digit percentage profit so far in 2024, with November as its best month, according to a person familiar with the situation. Bessent's even bigger wager is on Trump, the future president. He's been a donor, economic adviser and booster on TV to Trump, and Bessent is now seen as a likely candidate for a top economic role in the administration, such as running the U.S. Treasury Department or leading the White House National Economic Council. Trump has talked Bessent up as “one of the most brilliant men on Wall Street." Details of his fund's performance, reported here for the first time, show a mixed track record in the decade since he launched his own hedge fund firm. Ted Seides, the former president of Protege Partners, an investment firm where Bessent earned strong returns in the late 2000s, told Reuters that Bessent's track record should be taken in the context of macro investing, where big profits can be followed by less attractive returns. So-called macro hedge funds bet on global macroeconomic trends and are not open to retail investors. "If you only look at the part of a track record with lean years, it’s like saying Aaron Judge struck out a lot last year," Seides said, referring the baseball star known for hitting home runs. "But he was just named MVP." Bessent's candidacy in the hotly-contested role of Treasury Secretary or another economic role in the Trump administration has heightened interest in the fund manager. If he were to take a job in the new administration, Key Square could be wound down, sold, or put in "sleep mode," according to the same person. Trump recently floated the idea of appointing Kevin Warsh as Treasury Secretary on the understanding that he could later be Federal Reserve Chairman, the Wall Street Journal reported on Thursday, citing people familiar with the matter. The report also said Bessent might lead the White House National Economic Council and then become Treasury Secretary after Warsh. Bessent has long been considered a top contender to run Treasury. Karoline Leavitt, a spokesperson for Trump's transition team, said in an email that decisions on personnel "will continue to be announced by him when they are made." BIG START Bessent, who grew up in a small town in South Carolina and went to Yale College before landing on Wall Street, started Key Square in late 2015. The firm quickly raised $4.5 billion - then one of the largest hedge fund launches in history. That included $2 billion from famed macroeconomic investor George Soros, for whom Bessent had helped earn billions of dollars over two stints at Soros Fund Management. Key Square's main fund returns surged 13% in its first year, 2016, according to a second person familiar with the firm. That year, it gained on correctly predicting the British pound's decline around "Brexit," a vote for Britain to leave the European Union, according to the first person familiar with the situation. Later, Key Square made money when Bessent correctly anticipating a U.S. stock and dollar rally when Donald Trump was elected that November, according to the first person. But Key Square lost 7% in 2017, and then lost money or just broke even from 2018 to 2021, according to the second person and performance disclosures from one of its investors, New York City Police Pension Fund. The hedge fund gained double digits in both 2023 and 2024 and is up "double digits" over its history, according to the second person. That uneven performance appears to have scared away some clients. Assets under management shrank from a peak of around $5.1 billion at the end of 2017 to $577 million as of December 2023, while the number of institutional investors fell from 180 in December 2017 to 20 by the end of 2023, according to regulatory disclosures tracked by Convergence Inc. Soros took back most of his capital in 2018, per a previous agreement with Bessent to return the money, according to a third source familiar with the matter. Soros no longer has any money managed by Bessent, according to the third person. The two men have not spoken since 2016, Bessent said in a recent interview with Trump ally Roger Stone. Other large clients who no longer have money with Key Square include Australia's Future Fund, Morgan Stanley Alternative Investment Partners, and the New York City Police and Fire pension funds, according to public records and regulatory disclosures. One large hedge fund allocator told Reuters that they pulled their money several years ago from Key Square because the returns had been “too inconsistent.” Another large Key Square investor withdrew from the hedge fund last year because of Bessent’s support of Trump, according to the second person familiar with the firm. While Key Square's hedge fund assets have declined, it has other business lines that remain strong, including providing investment ideas to other money managers and an advisory business for family offices, foundations and endowments, according to the two people familiar with the firm. It also has plans to launch an ETF, according to a recent securities filing. The University of California redeemed its assets from Key Square amid a broader pull back from using hedge funds, but Bessent has remained "deep source of knowledge for us," chief investment officer, Jagdeep Singh Bachher, told Reuters via email. Another longtime client to stick with Key Square is Brevan Howard Asset Management, the $34 billion macro hedge fund manager co-founded by British billionaire Alan Howard. "Scott is one of the best macro investors in the world," a spokesperson for Brevan Howard said via email. "His understanding of markets, public policy, and the global economy is largely unmatched." Semafor previously reported that selective Key Square performance numbers were being shared around Wall Street chats as Bessent competed for the coveted post of U.S. Treasury Secretary. The report did not reveal the numbers shared. POLITICAL BET Bessent contributed to Trump’s inauguration following his 2016 election win. He was more involved during the 2024 election cycle, serving as an economic adviser to the campaign in addition to being a top fundraiser. Since the election, he has made TV appearances and written opinion pieces in support of Trump's proposed economic agenda. “I was all in for President Trump. I was one of the few Wall Street people backing him,” Bessent recent said in the interview with Stone. In January this year, Bessent predicted a “Trump Rally” in stocks as long as the Republican remained ahead in the election polls. “We are expecting an upward trajectory in the U.S. equity markets,” he wrote in the letter to Key Square clients. “Barring Biden pulling ahead in substantial fashion, all pullbacks should be bought.” This article was generated from an automated news agency feed without modifications to text.

Today, the U.S. government announced additional measures to further restrict semiconductor technology exports to China . Our initial assessment is that the effect of the announced measures on Lam's business will be broadly consistent with our prior expectations. As a result, at this time we have no plans to update Lam's financial guidance for the December 2024 quarter as stated in our earnings press release on October 23, 2024 . About Lam Research Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif. , with operations around the globe. Learn more at www.lamresearch.com . (LRCX) Caution Regarding Forward-Looking Statements: Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to but are not limited to the effect of U.S. government restrictions on semiconductor technology exports to China , the effect of such measures on Lam's business, and our outlook and guidance for future financial results. Some factors that may affect these forward-looking statements include: trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; our understanding of newly announced trade restrictions and their impact on our business may change over time; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; supply chain cost increases and other inflationary pressures have impacted and may continue to impact our profitability; supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; and natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10-K for the fiscal year ended June 30, 2024 and quarterly report on Form 10-Q for the quarter ended September 29, 2024 . These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this press release. Company Contacts: Ram Ganesh Investor Relations (510) 572-1615 Email: investor.relations@lamresearch.com Source: Lam Research Corporation### View original content to download multimedia: https://www.prnewswire.com/news-releases/lam-research-corporation-comments-on-newly-announced-export-regulations-302320046.html SOURCE Lam Research Corporation

AMMO Deadline: POWW Investors Have Opportunity to Lead AMMO, Inc. Securities Fraud LawsuitAMMO Deadline: POWW Investors Have Opportunity to Lead AMMO, Inc. Securities Fraud LawsuitQatar tribune F Willis Johnson As this election cycle draws to a close, I’m experiencing a whirlwind of emotions — hope and worry, resolve and trepidation, clarity and uncertainty. But above all, my abiding faith in the power of our collective voice and the sacredness of our vote fuels me. I’m a member of Generation X, a son of the African diaspora, a husband, a father and a minister. My journey has been shaped by the struggles and triumphs of those who paved the way and the promise of a better tomorrow for those who will follow. From this vantage point, I pen this appeal to you, Generations Next — the millennials and Generation Z. Current events serve as a powerful reminder of the weight and potential of the ballot. It’s not just a piece of paper or a screen tap; it’s a sacred tool for justice, equity and the promise of a more perfect union. For Black, Indigenous, and people of color (BIPOC+), the vote was a hard-fought accomplishment, a victory achieved through the sacrifice of blood, sweat and tears. The vote symbolizes the inherent worth of all in a nation that’s often fallen short of its highest aspirations. It’s a thread that connects us to the struggles and triumphs of those who came before us, shaping the narrative of our collective history. For example, the vote honors the suffragettes’ tireless struggle for basic rights in the face of ridicule, arrests and brutality. It was the way to realize women’s reproductive rights and equal pay. The vote remains the most powerful tool to secure their bodily autonomy, yet it is still under threat. The vote is a bulwark against turning back the clock even further. My young siblings, this election isn’t just political — it’s a moment that will reverberate through the annals of history. It’s a moral mandate, a testament to our democracy’s resilience and a defining choice for our nation’s soul. It’s a choice between a country where everyone is valued, every story is respected and every individual can thrive. A path down the dark alleys of division, inequality and despair threatens to extinguish our shared humanity’s essence. A choice resulting from some among us who are prepared to silence the voices of many, drown out the chorus of our collective conscience, revise history, distort the mirror that reflects our past and guides our future, bastardize our republic’s ideals and norms, profaning the sacred principles upon which our great nation was founded; as well as reduce our diversity’s majesty to a monochrome, draining the vibrant colors that make our tapestry so rich and robust. However, we, the people, hold the keys to our destiny. That is why I implore you to exercise this sacred right: Vote. In a democratic republic, your voice is articulated through the ballot. Every election, from the local school board to the presidency, is an opportunity to steer the direction of our communities and nation. Your vote matters. It is an instrument of personal and collective change to hold elected officials accountable and bring about reform. Your vote is representative of your values, the embodiment of your convictions put into action. It is the fulfillment of a moral obligation, a duty to participate in the democratic process that generations have fought to preserve. When you cast your ballot, you are shaping your family, community and country’s future. Do not take this right lightly. Please educate yourself on the issues, the candidates and their platforms. Then, go vote! If you didn’t know, change rests with a single action: casting a ballot. You’ve registered, educated yourself and maybe even mobilized others. There are some obstacles to navigate to ensure every voice is heard. No democracy is simple, easy or clean. However, you are not just a voter; you’re an architect. You are the chief designer of a better nation. You are an author writing the next chapter of the American story. It is a story of hope and resilience, multiethnic and interfaith. We are not waiting for change. Instead, each of us is offered an invitation to create it. I admonish you, young friends, to activate your superpower. If you need guidance or information visit websites like Vote.org and BallotReady that offer tools to check your registration, find your polling place, and research candidates and issues. Also, if you face harassment or intimidation at the polls, report it to the Election Protection Hotline (1-866-OUR-VOTE) or the Department of Justice Voting Rights Hotline (1-800-CALL-FBI). Vote like all our lives depend on it because they do. This plea is not just a simple ask from an “older” sibling; it’s a call to action to take up your role as a responsible citizen and to shape the future you want to see. (Johnson is a United Methodist pastor, the author of “ Holding Up Your Corner: Talking About Race in Your Community “ and program director for the Bridge Alliance, which houses The Fulcrum.) Copy 03/12/2024 10Advanced nuclear power a clean energy solution - Brent Ridge

NoneNEW YORK (AP) — U.S. stocks drifted to a mixed close, as gains for tech stocks nudged the S&P 500 and the Nasdaq to more records. The S&P 500 eked out a gain of under 0.1% Tuesday, while the Nasdaq composite rose 0.4%. The Dow Jones Industrial Average fell 0.2%. Treasury yields held relatively steady after a report showed U.S. employers were advertising slightly more job openings at the end of October than a month earlier. The value of the South Korean won sank against the dollar after its president declared martial law and then later said he’ll lift it. THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below. NEW YORK (AP) — U.S. stocks are drifting around their records on Tuesday as Wall Street's white-hot rally lets off the accelerator. The S&P 500 was virtually flat in afternoon trading, a day after rising tech stocks helped it set an all-time high for the 54th time this year. It's climbed in nine of the last 10 days and is on track for one of its best years since the turn of the millennium. The Dow Jones Industrial Average was down by 56 points, or 0.1%, with 45 minutes remaining in trading, while the Nasdaq composite added 0.2% to its own record set a day earlier. AT&T rose 3.9% after it boosted its profit forecast for the year. It also announced a $10 billion plan to send cash to its investors by buying back its own stock, while saying it expects to authorize another $10 billion of repurchases in 2027. On the losing end of Wall Street was U.S. Steel, which fell 7.9%. President-elect Donald Trump reiterated on social media that he would not let Japan’s Nippon Steel take over the iconic Pennsylvania steelmaker. Nippon Steel announced plans last December to buy the Pittsburgh-based steel producer for $14.1 billion in cash, raising concerns about what the transaction could mean for unionized workers, supply chains and U.S. national security. Earlier this year, President Joe Biden also came out against the acquisition. Tesla s sank 2.1% after a judge in Delaware reaffirmed a previous ruling that the electric car maker must revoke Elon Musk’s multibillion-dollar pay package. The judge denied a request by attorneys for Musk and Tesla’s corporate directors to vacate her ruling earlier this year requiring the company to rescind the unprecedented pay package. In the bond market, Treasury yields held relatively steady after a report showed U.S. employers were advertising slightly more job openings at the end of October than a month earlier. Continued strength there would raise optimism that the economy could keep avoiding a recession that many investors had earlier thought was inevitable. The yield on the 10-year Treasury rose to 4.22 from 4.20% from late Monday. Yields have seesawed since Election Day amid worries that Trump's preferences for lower tax rates and bigger tariffs could spur higher inflation along with economic growth. But traders are still confident the Federal Reserve will cut its main interest rate again at its next meeting in two weeks. They’re betting on a nearly three-in-four chance of that, according to data from CME Group. Lower rates can help give the economy more juice, but they can also give inflation more fuel. The key report this week that could guide the Fed’s next move will arrive on Friday. It’s the monthly jobs report , which will show how many workers U.S. employers hired and fired during November. It could be difficult to parse given how much storms and strikes distorted figures in October. Based on trading in the options market, Friday's jobs report appears to be the biggest potential market mover until the Fed announces its next decision on interest rates Dec. 18, according to strategists at Barclays Capital. Since his victory, Trump has broadcasted his plans for tariffs , including for goods coming from China . Trade relations between the U.S. and China took another step backward after China said it is banning exports to the U.S. of gallium, germanium, antimony and other key high-tech materials with potential military applications. The counterpunch came swiftly after the U.S. Commerce Department expanded the list of Chinese technology companies subject to export controls to include many that make equipment used to make computer chips, chipmaking tools and software. The 140 companies newly included in the so-called “entity list” are nearly all based in China. In financial markets abroad, the value of South Korea's currency fell 0.9% against the U.S. dollar following a frenetic night where President Yoon Suk Yeol declared martial law and then later said he'd lift it after lawmakers voted to reject military rule. Stocks of Korean companies that trade in the United States also fell, including a 1.3% drop for SK Telecom. Japan’s Nikkei 225 jumped 1.9% to help lead global markets. Some analysts think Japanese stocks could end up benefiting from Trump’s threats to raise tariffs on China and other countries. Indexes rose 1% in Hong Kong and 0.4% in Shanghai amid unconfirmed reports that Chinese leaders would meet next week to discuss planning for the coming year. Investors are hoping it may bring fresh stimulus to help spur growth in the world’s second-largest economy. In France, the CAC 40 rose 0.3% amid continued worries about politics in Paris , where the government is battling over the budget. ___ AP Business Writers Yuri Kageyama and Matt Ott contributed. Stan Choe, The Associated Press